Evidence map›Paper›PMID 39136916›Full record

ArticleCardiology and therapy2024

All-Cause Mortality of Atrial Fibrillation and Heart Failure in the Same Patient: Does the Order Matter?

Tímea Papp, György Rokszin, Zoltán Kiss, Dávid Becker, Béla Merkely, Zoltán Járai, András Jánosi, Zoltán Csanádi

Abstract read
In one paragraph

Article in Cardiology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tímea PappDivision of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, 22 Móricz Zsigmond Street, 4032, Debrecen, Hajdú-Bihar County, Hungary. papptimeabianka@gmail.com.ORCID http://orcid.org/0000-0001-6266-4601
György RokszinRxTarget Ltd., 10/2 Bacsó Nándor Street, 5000, Szolnok, Hungary.
Zoltán KissSecond Department of Medicine and Nephrology-Diabetes Center, Faculty of Medicine Pécs, University of Pécs, 1 Pacsirta Street, 7624, Pécs, Hungary.
Dávid BeckerHeart and Vascular Centre, Faculty of Medicine, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Béla MerkelyHeart and Vascular Centre, Faculty of Medicine, Semmelweis University, 68 Városmajor Street, 1122, Budapest, Hungary.
Zoltán JáraiDepartment of Cardiology, St. Imre University Teaching Hospital, 12-16 Tétényi Street, 1115, Budapest, Hungary.
András JánosiGottsegen National Cardiovascular Institute, 29 Haller Street, 1096, Budapest, Hungary.
Zoltán CsanádiDivision of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, 22 Móricz Zsigmond Street, 4032, Debrecen, Hajdú-Bihar County, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAtrial fibrillation (AF) and heart failure (HF) often coexist due to the common elements of the pathomechanism they share. The potential significance of the order these entities present in the same patient is ill-defined. Herein, we report our results from a nationwide database on the occurrence of various sequences AF and HF may present, the time delays between the two conditions and all-cause mortality associated with different scenarios.

methodsPatients diagnosed with both AF and HF between 2015 and 2021 were enrolled from the Hungarian National Health Insurance Fund (NHIF) database. The order the two entities followed each other, and the time delay in between were registered. Median survival rates were calculated in AF → HF; HF → AF and simultaneous scenarios.

resultsA total of 109,075 patients were enrolled: 29,937 with AF → HF, 38,171 with HF → AF, and 40,967 diagnosed simultaneously. Time delays between AF → HF and HF → AF were 6 and 10 months, respectively. The median survival was 46 months in the AF → HF, 38 months in the HF → AF, and 21 months in the simultaneous group. Patients with HF → AF, and with simultaneous presentations had 5% and 16% greater mortality risk as compared to the AF → HF sequence, with hazard ratios (95% confidence intervals) of 0.95 (0.93-0.97) and 0.84 (0.82-0.85), respectively (P < 0.0001).

conclusionsHF occurred significantly earlier after the diagnosis of AF than vice versa. Patients diagnosed simultaneously had the worst, while the AF → HF sequence had the best prognosis. These data should have implications for the intensification of monitoring and therapy in different scenarios.

Indexed as

Atrial fibrillationHeart failureMortality riskReal-world evidence

Identifiers

PMID39136916
PMCPMC11333397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.